HTANALYSTS is an Australian healthcare consultancy specialising in health economics and outcomes research (HEOR), health technology assessment (HTA), and market access strategy.
For over 20 years, we have supported government, industry, and not-for-profit organisations to make evidence-based decisions across healthcare, public health, and the broader social sector. Our work combines economic modelling, evidence synthesis, and impact evaluation to inform funding, reimbursement, and policy outcomes.
We design and deliver rigorous analytical work to answer complex questions, including:
How should new health technologies be assessed and funded
What is the clinical and economic value of an intervention
How can programs demonstrate measurable impact
What evidence is required to navigate reimbursement pathways
Our expertise spans:
Health economics and economic evaluation
Evidence generation and synthesis
Market access and reimbursement strategy
Modelling and analytics
Social impact assessment and evaluation
We work across pharmaceuticals, medical devices, diagnostics, and public health programs, with experience in areas such as oncology, rare diseases, genomics, vaccines, aged care, and disability.
Through our events, we aim to translate technical concepts into practical insights. We bring together industry, government, and research perspectives to support better decision-making and improve outcomes across the healthcare system.
